Potential of Orally Administered Quercetin, Hesperidin, and p-Coumaric Acid in Suppressing Intra-/Extracellular Advanced Glycation End-Product-Induced Cytotoxicity in Proximal Tubular Epithelial Cells
- Takanobu Takata 1,2, Junji Moriya 3,4, Katsuhito Miyazawa 5, Sohsuke Yamada 6,7, Jia Han 6,7, Qian Yang 8,9, Xin Guo 9,10, Takeshi Nakahashi 3,4, Shuichi Mizuta 3, Shinya Inoue 5,11, Togen Masauji 2, Yoshiharu Motoo 12
- Takanobu Takata 1,2, Junji Moriya 3,4, Katsuhito Miyazawa 5
- 1Division of Molecular and Genetic Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
- 2Department of Pharmacy, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan.
- 3Department of General Internal Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
- 4General Medical Center, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan.
- 5Department of Urology, Kanazawa Medical University Hospital, Uchinada 920-0393, Ishikawa, Japan.
- 6Department of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
- 7Department of Pathology, Kanazawa Medical University Hospital, Uchinada 920-0293, Ishikawa, Japan.
- 8Department of Spleen and Stomach Diseases, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang 050011, China.
- 9Hebei Key Laboratory of Turbidity Toxin Syndrome, Shijiazhuang 050011, China.
- 10Research Center, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang 050011, China.
- 11Inoue Iin Clinic, Kusatsu 525-0034, Shiga, Japan.
- 12Department of Internal Medicine, Fukui Saiseikai Hospital, Wadanaka 918-8503, Fukui, Japan.
- 0Division of Molecular and Genetic Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada 920-0293, Ishikawa, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Japanese folk medicine compounds like quercetin and hesperidin may protect kidney cells from damage caused by advanced glycation end-products (AGEs). These compounds and p-coumaric acid show potential in preventing AGE-related kidney dysfunction.
Area Of Science
- Nephrology
- Pharmacology
- Natural Products Chemistry
Background
- Advanced glycation end-products (AGEs) contribute to proximal tubular epithelial (PTE) cell dysfunction in lifestyle diseases.
- Urinary stones cause cytotoxicity in PTE cells, necessitating therapeutic interventions.
- Japanese folk medicine utilizes *Quercus salicina*/*Q. stenophylla* leaves, known to contain bioactive compounds.
Purpose Of The Study
- To review the effects of quercetin, hesperidin, and p-coumaric acid on PTE cells.
- To investigate the metabolism of these compounds after oral administration.
- To explore their role in mitigating AGE-induced cytotoxicity and generation in PTE cells.
Main Methods
- Literature review of existing preclinical and clinical studies.
- Analysis of metabolic pathways of quercetin, hesperidin, and p-coumaric acid.
- Assessment of their impact on AGEs and PTE cell cytotoxicity.
Main Results
- Non-metabolized quercetin and p-coumaric acid may suppress AGE-induced cytotoxicity in PTE cells.
- Metabolites of quercetin and hesperidin show potential in inhibiting AGE generation.
- The combined effect of these compounds may offer collective protection against AGEs in PTE cells.
Conclusions
- Quercetin, hesperidin, and p-coumaric acid from *Q. salicina*/*Q. stenophylla* show promise in managing AGE-related PTE cell damage.
- Further preclinical and clinical research is warranted to validate these findings.
- Understanding the metabolism of these compounds is crucial for therapeutic development.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

